Amedisys will hone its acquisitional focus more toward the home health care space heading into next year, Hospice News reports. Soaring valuations in hospice, along with a crowded market and the complexity of integrating these assets are among the factors pulling the company’s gaze, according to CEO Paul Kusserow.
The hospice merger and acquisitions market has been hot in recent years, with a rising volume of deals taking place and record-high valuations outpacing those in other health care sectors. Multiples in the hospice and home care space hit a record 26x, according to a report by PwC’s Health Research Institute. Read more.
